---
title: "Idarubicin - Acute Promyelocytic Leukemia, Fab M3"
sidebar: mydoc_sidebar
permalink: db01177-mesh-d015473-1.html
toc: false 
---


Path ID: `DB01177_MESH_D015473_1`
{% include image.html url="images/db01177-mesh-d015473-1.png" file="db01177-mesh-d015473-1.png" alt="db01177-mesh-d015473-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D015255">MESH:D015255 </a> | idarubicin | Drug |
| <a href="https://identifiers.org/GO:0001207">GO:0001207 </a> | histone displacement | BiologicalProcess |
| <a href="https://identifiers.org/GO:0009299">GO:0009299 </a> | mRNA transcription | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P11388">UniProt:P11388 </a> | DNA topoisomerase 2-alpha | Protein |
| <a href="https://identifiers.org/GO:0032993">GO:0032993 </a> | protein-DNA complex | CellularComponent |
| <a href="https://identifiers.org/MESH:D005609">MESH:D005609 </a> | Free Radicals | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D004249">MESH:D004249 </a> | DNA Damage | BiologicalProcess |
| <a href="https://identifiers.org/GO:0006260">GO:0006260 </a> | DNA replication | BiologicalProcess |
| <a href="https://identifiers.org/HP:0031377">HP:0031377 </a> | Abnormal cell proliferation | PhenotypicFeature |
| <a href="https://identifiers.org/GO:0006915">GO:0006915 </a> | apoptotic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0140014">GO:0140014 </a> | mitotic nuclear division | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D015473">MESH:D015473 </a> | Acute promyelocytic leukemia, FAB M3 | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Idarubicin | CONTRIBUTES TO | Histone Displacement |
| Histone Displacement | NEGATIVELY CORRELATED WITH | Mrna Transcription |
| Mrna Transcription | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Idarubicin | NEGATIVELY REGULATES | Mitotic Nuclear Division |
| Mitotic Nuclear Division | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Abnormal Cell Proliferation | POSITIVELY CORRELATED WITH | Acute Promyelocytic Leukemia, Fab M3 |
| Idarubicin | DECREASES ABUNDANCE OF | Protein-Dna Complex |
| Protein-Dna Complex | HAS PARTICIPANT | Dna Topoisomerase 2-Alpha |
| Dna Topoisomerase 2-Alpha | POSITIVELY CORRELATED WITH | Dna Replication |
| Idarubicin | INCREASES ABUNDANCE OF | Free Radicals |
| Free Radicals | POSITIVELY CORRELATED WITH | Dna Damage |
| Dna Damage | POSITIVELY CORRELATED WITH | Apoptotic Process |
| Apoptotic Process | NEGATIVELY CORRELATED WITH | Acute Promyelocytic Leukemia, Fab M3 |
| Dna Replication | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Dna Replication | POSITIVELY CORRELATED WITH | Mitotic Nuclear Division |
| Mitotic Nuclear Division | POSITIVELY CORRELATED WITH | Abnormal Cell Proliferation |
| Abnormal Cell Proliferation | MANIFESTATION OF | Acute Promyelocytic Leukemia, Fab M3 |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01177](https://go.drugbank.com/drugs/DB01177)
  - [https://en.wikipedia.org/wiki/Idarubicin](https://en.wikipedia.org/wiki/Idarubicin)
